Breaking News Instant updates and real-time market news.

VRX

Valeant

$13.45

-0.02 (-0.15%)

12:32
05/19/17
05/19
12:32
05/19/17
12:32

Wells says generic Apriso competition may come much sooner than Valeant expected

After the U.S. Patent Office's Trials and Appeal Board ruled that patents related to Valeant's Apriso were unpatentable, Wells Fargo analyst David Maris said the decision may allow generic competition to the ulcerative colitis drug a "dozen years" earlier than Valeant anticipated. Valeant's 2016 10-K does not list Apriso as one of products the company sees facing generic competition between 2017 and 2021, noted Maris, who adds that it is possible that Valeant appeals the PTAB decision. Maris keeps an Underperform rating on Valeant shares.

  • 22

    May

  • 06

    Jun

  • 24

    Aug

VRX Valeant
$13.45

-0.02 (-0.15%)

05/09/17
WELS
05/09/17
NO CHANGE
WELS
Underperform
Valeant key products continue to underperform, says Wells Fargo
Following the company's Q1 results, Wells Fargo analyst David Maris says Valeant Pharmaceuticals' key products continue to underperform. Valeant's decision to highlight in its press release the EBITDA raise of 1.3% is understandable, as this is better than the recent trend, but the $50M raise is relative to approximately $28.9B of total debt, Maris tells investors in a research note. Key products and areas such as Xifaxan and Bausch + Lomb continue to underperform, the analyst contends. He keeps an Underperform rating on Valeant with an $8 price target. The stock in morning trading is up 15%, or $1.48, to $11.19.
05/09/17
JPMS
05/09/17
NO CHANGE
JPMS
Neutral
Valeant's road to recovery remains long, says JPMorgan
JPMorgan analyst Chris Schott finds today's rally in Valeant Pharmaceuticals unsurprising as EBITDA guidance was raised following significant cuts over the past year. That said, the analyst continues to see a "long road to recovery for the story." He keeps a Neutral rating on the shares. Valeant is up 18%, or $1.79, to $11.50 in midday trading.
05/11/17
WELS
05/11/17
NO CHANGE
Target $9
WELS
Underperform
Valeant estimates reduced on weakening fundamentals at Wells Fargo
Wells Fargo analyst David Maris said the reaction to Valeant's guidance is too positive and notes leverage has increased, most businesses missed his forecasts, and the increase in EBITDA guidance was due to changes in how it accounts for foreign exchange. The analyst lowered estimates and reiterated his Underperform rating given the company's deteriorating fundamentals, adding that he expects the recent share strength to be temporary. However, he increased his price target on the shares to $9 from $8, noting Valeant's Q1 showed a "dramatic decline" in working capital.
05/19/17
DBAB
05/19/17
NO CHANGE
Target $18
DBAB
Hold
Deutsche Bank 'warming up' to Valeant story
In a research note titled "Warming up to VRX," Deutsche Bank analyst Gregg Gilbert says that while Valeant Pharmaceuticals is "not out of the woods," the worst fears may be subsiding. The analyst continues to view the company's near-term setup as "encouraging." Valeant's 2017 outlook seems reachable, asset sales in the near- and medium-term seem likely, and the recent refinancing provided more time and flexibility for the company to deal with its issues, Gilbert tells investors. He also believes the worst case for Xifaxan of near-term generic competition "seems to be off the table for now." The analyst keeps a Hold rating on Valeant with an $18 price target. The drugmaker closed yesterday up 22c to $13.47.

TODAY'S FREE FLY STORIES

02:45
05/25/17
05/25
02:45
05/25/17
02:45
General news
FX Action: The dollar has been trading softer »

FX Action: The dollar has…

21:10
05/24/17
05/24
21:10
05/24/17
21:10
General news
Breaking General news story  »

Chicago Federal Reserve…

MB

Mindbody

$27.95

0.1 (0.36%)

20:37
05/24/17
05/24
20:37
05/24/17
20:37
Syndicate
Mindbody 4.4M share Secondary priced at $27.95 »

JPMorgan, UBS, Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 14

    Jun

  • 25

    May

MDT

Medtronic

$84.70

0.09 (0.11%)

, DLTR

Dollar Tree

$78.08

-0.77 (-0.98%)

20:25
05/24/17
05/24
20:25
05/24/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$84.70

0.09 (0.11%)

DLTR

Dollar Tree

$78.08

-0.77 (-0.98%)

HRL

Hormel Foods

$35.40

0.19 (0.54%)

BBY

Best Buy

$50.42

-1.13 (-2.19%)

SIG

Signet Jewelers

$54.53

-3.85 (-6.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 25

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 06

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

WUBA

58.com

$44.02

0.36 (0.82%)

20:11
05/24/17
05/24
20:11
05/24/17
20:11
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q2 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

WUBA

58.com

$44.02

0.36 (0.82%)

20:10
05/24/17
05/24
20:10
05/24/17
20:10
Earnings
58.com reports Q1 EPS 10c, consensus (25c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

SNAP

Snap

$20.53

0.5 (2.50%)

20:07
05/24/17
05/24
20:07
05/24/17
20:07
Periodicals
Snapchat Shows outperforming internal targets, Variety says »

As part of a larger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 28

    Jun

  • 19

    Jul

EPC

Edgewell Personal Care

$72.45

0.36 (0.50%)

, PG

Procter & Gamble

$86.50

0.42 (0.49%)

19:53
05/24/17
05/24
19:53
05/24/17
19:53
Hot Stocks
Edgewell shave brand Schick launches subscription service »

Edgewell Personal Care…

EPC

Edgewell Personal Care

$72.45

0.36 (0.50%)

PG

Procter & Gamble

$86.50

0.42 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WOW

WideOpenWest

19:49
05/24/17
05/24
19:49
05/24/17
19:49
Syndicate
WideOpenWest 18.2M share IPO priced at $17.00, below the range »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

SFTBF

SoftBank

$76.21

-0.585 (-0.76%)

, S

Sprint

$8.17

-0.01 (-0.12%)

19:44
05/24/17
05/24
19:44
05/24/17
19:44
Hot Stocks
SoftBank nominates Sprint CEO to board »

SoftBank (SFTBF)…

SFTBF

SoftBank

$76.21

-0.585 (-0.76%)

S

Sprint

$8.17

-0.01 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNDX

Syndax

$13.89

-0.78 (-5.32%)

19:44
05/24/17
05/24
19:44
05/24/17
19:44
Syndicate
Syndax 3.75M share Secondary priced at $13.25 »

Morgan Stanley, Citi and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 25

    May

JELD

JELD-WEN Holding

$31.21

0.95 (3.14%)

19:29
05/24/17
05/24
19:29
05/24/17
19:29
Syndicate
JELD-WEN Holding 14M share Secondary priced at $30.75 »

Barclays, Citi, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

CWH

Camping World

$27.87

0.19 (0.69%)

19:27
05/24/17
05/24
19:27
05/24/17
19:27
Syndicate
Camping World 9.5M share Secondary priced at $27.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

PBR

Petrobras

$9.08

0.25 (2.83%)

19:17
05/24/17
05/24
19:17
05/24/17
19:17
Hot Stocks
Petrobras notified of dismissal of popular interest suit in shallow water case »

Petrobras reports that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$13.40

0.09 (0.68%)

19:17
05/24/17
05/24
19:17
05/24/17
19:17
Periodicals
Etsy downscales intern program, Bloomberg says »

Etsy is slashing its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$954.96

6.14 (0.65%)

, GOOGL

Alphabet Class A

$977.61

7.06 (0.73%)

19:09
05/24/17
05/24
19:09
05/24/17
19:09
Hot Stocks
Google introduces marketing measurement tool 'Ads Data Hub' »

As part of its annual…

GOOG

Alphabet

$954.96

6.14 (0.65%)

GOOGL

Alphabet Class A

$977.61

7.06 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 01

    Jun

  • 28

    Jun

  • 19

    Jul

PTCT

PTC Therapeutics

$12.58

-0.92 (-6.81%)

19:04
05/24/17
05/24
19:04
05/24/17
19:04
Hot Stocks
PTC Therapeutics director Svoronos acquires 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jun

  • 24

    Oct

NVDA

Nvidia

$138.57

1.54 (1.12%)

, GOOG

Alphabet

$954.96

6.14 (0.65%)

19:04
05/24/17
05/24
19:04
05/24/17
19:04
Hot Stocks
NVIDIA CEO on Google AI chip: Great to see two leaders race »

In a company blog post…

NVDA

Nvidia

$138.57

1.54 (1.12%)

GOOG

Alphabet

$954.96

6.14 (0.65%)

GOOGL

Alphabet Class A

$977.61

7.06 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 01

    Jun

  • 09

    Jun

  • 28

    Jun

  • 19

    Jul

TSO

Tesoro

$83.09

0.07 (0.08%)

19:02
05/24/17
05/24
19:02
05/24/17
19:02
Hot Stocks
Tesoro says Western Rifing deal waiting period has terminated »

Tesoro Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$29.13

0.01 (0.03%)

19:02
05/24/17
05/24
19:02
05/24/17
19:02
Hot Stocks
Kroger recalls Yellow Sponge Cake dessert cups containing undeclared milk »

The Kroger Company has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SZEVY

Suez

$9.18

0.065 (0.71%)

18:59
05/24/17
05/24
18:59
05/24/17
18:59
Downgrade
Suez rating change at Goldman Sachs »

Suez downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SABR

Sabre

$23.09

0.17 (0.74%)

18:48
05/24/17
05/24
18:48
05/24/17
18:48
Hot Stocks
Sabre sees approximately $80M-$100M charge associated with Air Berlin contract »

On May 24, Sabre…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 01

    Jun

CONN

Conn's

$15.40

-0.15 (-0.96%)

18:33
05/24/17
05/24
18:33
05/24/17
18:33
Hot Stocks
Conn's announces departure of Michael Poppe, COO, Credit and Collections »

On May 23, Conn's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

QDEL

Quidel

$24.62

0.01 (0.04%)

18:32
05/24/17
05/24
18:32
05/24/17
18:32
Hot Stocks
Quidel says PMDA of Japan approves Sofia Influenza A+B Assay »

Quidel announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$17.38

-0.18 (-1.03%)

18:32
05/24/17
05/24
18:32
05/24/17
18:32
Hot Stocks
Sally Beauty CEO acquires 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.